Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
127.81
0.00 (0.00%)
Oct 27, 2025, 8:00 PM EDT
Novartis AG Market Cap
Novartis AG has a market cap or net worth of $239.27 billion as of October 29, 2025. Its market cap has increased by 2.60% in one year.
Market Cap
239.27B
Enterprise Value
262.09B
Revenue
56.37B
Ranking
n/a
PE Ratio
16.62
Stock Price
$127.81
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 127.35B to 239.27B, an increase of 87.89%. That is a compound annual growth rate of 2.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 239.27B | 22.38% |
| Dec 30, 2024 | 195.51B | -5.62% |
| Dec 29, 2023 | 207.17B | 6.54% |
| Dec 30, 2022 | 194.45B | -1.02% |
| Dec 30, 2021 | 196.46B | -8.76% |
| Dec 30, 2020 | 215.32B | 0.17% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LogicMark | 1.43B |
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 668.66M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 394.58M |
| Silence Therapeutics | 337.25M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 320.50M |